APA (7th ed.) Citation

Syberg, M., Andersen, R., Presti, M., Bjoernhart, B., Moller, A., Frank, M., . . . Donia, M. (2025). 1547P Clinical outcomes of patients with acquired resistance to checkpoint inhibitors in melanoma, renal cell carcinoma and non-small cell lung cancer. Annals of Oncology, 36, S924. https://doi.org/10.1016/j.annonc.2025.08.2178

Chicago Style (17th ed.) Citation

Syberg, M.J, et al. "1547P Clinical Outcomes of Patients with Acquired Resistance to Checkpoint Inhibitors in Melanoma, Renal Cell Carcinoma and Non-small Cell Lung Cancer." Annals of Oncology 36 (2025): S924. https://doi.org/10.1016/j.annonc.2025.08.2178.

MLA (9th ed.) Citation

Syberg, M.J, et al. "1547P Clinical Outcomes of Patients with Acquired Resistance to Checkpoint Inhibitors in Melanoma, Renal Cell Carcinoma and Non-small Cell Lung Cancer." Annals of Oncology, vol. 36, 2025, p. S924, https://doi.org/10.1016/j.annonc.2025.08.2178.